Gene Editing Delivery Summit Embassy Suites by Hilton Boston at Logan Airport, Boston

Are you refining and optimizing your in vivo gene editing delivery strategies for the next generation of gene editors to unlock increased therapeutic efficacy, safety, and cost effectiveness?

Recent clinical trial successes from the likes of Editas Medicine and Tessera Therapeutics have highlighted the importance of targeted delivery for the safety and efficacy of in vivo gene editing. Formulation and delivery experts are uniting to evaluate and optimize cutting edge delivery strategies including LNPs, AAVs, exosomes, peptide shuttles, and polymer nanoparticles at the Gene Editing Delivery Summit. Leverage this insight to supercharge precise and efficient extra-hepatic in vivo gene editing to patients with previously untreatable genetic diseases.

Take advantage of the end-to-end content from discovery, optimization, evaluation, and scale-up topics covered in 2 hands-on workshops and 2 full days of data-driven case studies and discussion sessions from trailblazing drug developers such as Prime Medicine, Beam Therapeutics, Editas Medicine, and AstraZeneca to guide your in vivo gene editing delivery strategies for regulatory approval.